A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

MEN with aggressive prostate cancer could benefit from a new drug combination that slows cancer growth, scientists say.

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

Thousands of men with incurable prostate cancer could live longer thanks to a breakthrough study that found combining two ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

A new drug combination has offered a ray of hope for men with advanced prostate cancer.According to a research published in ...

CHICAGO — A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn't ...

Benign prostatic hyperplasia (BPH) and overactive bladder (OAB) syndrome are distinct health conditions but may cause similar symptoms, such as urgent or frequent urination. BPH is the noncancerous ...